DMRT2 is a transcriptional regulator located on chromosome 9 that functions as a DNA-binding transcription factor with dual roles in embryonic development and metabolic regulation. During embryogenesis, DMRT2 acts as a transcriptional activator that directly regulates MYF5 expression through sequence-specific binding to the early epaxial enhancer, playing a critical role in somitogenesis and somite differentiation into sclerotome, dermomyotome, and myotome 1. The gene generates multiple transcript isoforms with distinct coding potential, including bicistronic variants encoding additional polypeptides 1. In the adult kidney, DMRT2 demonstrates antagonistic regulation with transcription factors Hmx2 and Hmx3 to specify intercalated cell subtypes 2. DMRT2 promotes type A intercalated cell differentiation while repressing type B identity through mutually exclusive expression patterns, essential for maintaining systemic acid-base homeostasis 3. Additionally, DMRT2 interacts with the farnesoid X receptor (FXR) in adipose tissue to improve insulin sensitivity and attenuate HDF-induced insulin resistance 4. Clinically, DMRT2 deletions occur in 9p deletion syndrome, which affects diverse developmental and physiological processes 56. The gene's downregulation in insulin-resistant states highlights its metabolic significance beyond developmental functions.